XRHealth Acquires Swing Therapeutics to Expand Digital Chronic Pain Care Platform

Acquisition adds FDA-authorised fibromyalgia therapy and strengthens smartphone-based digital health offering

XRHealth has acquired Swing Therapeutics, expanding its digital therapeutics portfolio beyond virtual reality and into smartphone-based care for chronic pain and fibromyalgia.

The acquisition brings together XRHealth's extended reality (XR) therapies with Swing's FDA-authorised digital therapeutic, Stanza, and its virtual chronic pain management platform, creating a broader digital care ecosystem for patients living with long-term pain conditions.

The deal also reflects a wider trend across digital health, where companies are combining software, connected devices and virtual clinical services to deliver more scalable healthcare outside traditional clinical settings.

XRHealth broadens digital therapeutics portfolio

XRHealth has built its business around immersive therapeutic technologies, including virtual reality (VR) programmes used to support pain management, mental health and cognitive rehabilitation.

Its flagship FDA-registered VR platform is prescribed as Durable Medical Equipment (DME), allowing patients to receive clinician-guided therapy remotely.

With the acquisition of Swing Therapeutics, XRHealth is expanding beyond immersive technologies into smartphone applications, wearable devices and connected digital care.

The combined platform now supports patients through multiple digital treatment modalities depending on clinical need.

Stanza becomes part of XRHealth's chronic pain offering

A key asset in the acquisition is Stanza, the first FDA-authorised digital behavioural therapy specifically indicated for fibromyalgia symptoms.

Delivered through a smartphone application, Stanza is designed to help patients manage chronic pain using evidence-based behavioural interventions without requiring medication or invasive procedures.

The therapy was evaluated in a Phase III randomised controlled trial published in The Lancet, where patients demonstrated significant improvements across multiple clinical outcomes, including:

• Fibromyalgia symptom severity

• Pain intensity

• Fatigue

• Sleep quality

• Depression
  

The programme is delivered through Swing Care, a virtual clinic that combines digital therapy with clinician oversight, medication management, mental health support and personalised coaching.

According to the company, thousands of patients have already received treatment through the platform.

Virtual care model delivers long-term support

Swing Care extends beyond digital therapy by integrating licensed clinicians into the treatment pathway.

Reported one-year outcomes showed:

• 88% of patients experienced improvements in overall wellbeing

• 50.2% reported feeling "much improved" or better after treatment
  

Following the acquisition, XRHealth plans to incorporate these services into its existing network of virtual clinics using its established reimbursement model.

The combined platform aims to offer patients a more comprehensive approach to chronic pain management while improving access to specialist care.

Digital health consolidation continues

The Swing acquisition continues XRHealth's strategy of building an integrated digital healthcare platform through targeted acquisitions.

Recent deals include:

• RealizedCare (2025) – adding chronic pain and behavioural health programmes alongside AI-supported patient triage.

• Innerworld – bringing avatar-based virtual mental health communities.

• NeuroReality (2024) – expanding neurological rehabilitation capabilities.

• Amelia Virtual Care (2023) – strengthening immersive therapeutic technologies.
  

Each acquisition has expanded XRHealth's ability to deliver remote care across physical, cognitive and behavioural health conditions.

Meeting growing demand for scalable chronic pain care

Chronic pain remains one of healthcare's largest unmet needs, placing significant pressure on healthcare systems facing clinician shortages and rising patient demand.

Digital therapeutics are increasingly viewed as one solution to improving access while reducing the reliance on in-person appointments.

By combining virtual reality therapy, smartphone-based digital therapeutics, wearable technologies and clinician-led virtual care, XRHealth is positioning itself as a broader digital health platform capable of supporting patients across multiple treatment settings.

What the acquisition means

The acquisition demonstrates how the digital therapeutics market is evolving beyond single technologies towards integrated care platforms.

Rather than focusing solely on virtual reality, XRHealth now combines immersive therapies, mobile applications and virtual clinical services under one ecosystem.

As healthcare providers continue to adopt remote care models, platforms capable of delivering evidence-based treatment across multiple digital channels are expected to play an increasingly important role in chronic disease management, particularly in areas such as chronic pain, behavioural health and

---

Discover how nuaxia can support your next medical education initiative:

• Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector 

• Contact us on: support@nuaxia.com